{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T06:10:05Z","timestamp":1756793405313,"version":"3.44.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Gastric cancer (GC) is a very aggressive, with extreme heterogeneity and rapid growth, most frequently manifested histologically as stomach adenocarcinoma (STAD). Current evidence suggests that histone acetylation is critical for the origin and development of tumors. However, the significance of histone acetylation-related gene signatures for prognosis of STAD patients and mechanisms of histone acetylation in STAD therapy remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We identified histone acetylation-related genes in STAD from TCGA and constructed eight-gene signatures by utilizing a univariate Cox regression model with the Least Absolute Shrinkage and Selection Operator (LASSO). In addition, a nomogram was plotted to predict the prognostic significance of the established risk model. We examined associations between our gene signature and somatic mutation, immune subtype, clinicopathological features, tumor microenvironment, immune cell infiltration and immune activity, immunotherapy prediction and drug sensitivity. Cell-based assays were performed to determine the relationship between Doublecortin Like Kinase 1 (DCLK1) and the proliferation, migration and oxaliplatin resistance of GC cells <jats:italic>in vitro<\/jats:italic>. Immunohistochemical experiments were used to explore the relationship between DCLK1 and clinicopathological parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A prognostic model composed of eight histone acetylation-related genes in STAD was developed. Based on median risk score, the STAD patients were equally assigned into two groups of high- and low-risk, where high-risk represented a less favorable prognosis than low-risk. The two groups showed significant differences with respect to somatic mutation, immune subtype, clinicopathological features, tumor microenvironment, immune cell infiltration and immune activity, immunotherapy prediction and drug sensitivity. The results generated during Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses suggested that Differentially Expressed Genes (DEGs) in the two groups were involved in cancer-related processes and pathways. Cell-based assays indicated that DCLK1 is a promoting factor in gastric cancer and can promote oxaliplatin resistance in gastric cancer cells. Increased DCLK1 expression was also associated with Borrmann\u2019s Type, depth of invasion, lymph node metastasis, and TNM stage in GC patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A novel histone acetylation-related gene signature, which possesses potential value in predicting the prognosis and immunotherapy effectiveness regarding STAD patients, was developed. This signature may serve as a reliable biomarker for prognosis of STAD and promote the identification of novel treatment targets for STAD. Furthermore, DCLK1 exhibited oncogenic roles and may be a new target for STAD therapy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1527253","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T05:32:20Z","timestamp":1756791140000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The histone acetylation-related gene signature predicts prognosis and immunotherapy response in stomach adenocarcinoma"],"prefix":"10.3389","volume":"15","author":[{"given":"Chen","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishun","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songcheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1002\/cncr.30881","article-title":"Stomach cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study","author":"Jim","year":"2017","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10120-017-0707-8","article-title":"Second-line chemotherapy for patients with advanced gastric cancer","volume":"20","author":"Takahari","year":"2017","journal-title":"Gastric Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21657","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.114.173492","article-title":"What do you mean, \u201cepigenetic\u201d","volume":"199","author":"Deans","year":"2015","journal-title":"Genetics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.crvi.2016.05.009","article-title":"From Mendel to epigenetics: History of genetics","volume":"339","author":"Gayon","year":"2016","journal-title":"C R Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-pharmtox-010716-105106","article-title":"Targeting epigenetics in cancer","volume":"58","author":"Bennett","year":"2018","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pharmthera.2016.01.011","article-title":"Aberrant lysine acetylation in tumorigenesis: Implications in the development of therapeutics","volume":"162","author":"Kaypee","year":"2016","journal-title":"Pharmacol Ther"},{"key":"B10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/SLA.0000000000003393","article-title":"Driver gene mutations and epigenetics in colorectal cancer","volume":"271","author":"Raskov","year":"2020","journal-title":"Ann Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2217\/epi.14.59","article-title":"Epigenetic mechanisms of breast cancer: an update of the current knowledge","volume":"6","author":"Karsli-Ceppioglu","year":"2014","journal-title":"Epigenomics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1021\/tx200378c","article-title":"Epigenetic events associated with breast cancer and their prevention by dietary components targeting the epigenome","volume":"25","author":"Khan","year":"2012","journal-title":"Chem Res Toxicol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.embor941","article-title":"Regulating histone acetyltransferases and deacetylases","volume":"4","author":"Legube","year":"2003","journal-title":"EMBO Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-013-0204-7","article-title":"Acetyltransferases (HATs) as targets for neurological therapeutics","volume":"10","author":"Schneider","year":"2013","journal-title":"Neurotherapeutics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2013.06.001","article-title":"Transcriptional control of cancer metastasis","volume":"23","author":"Ell","year":"2013","journal-title":"Trends Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19167","article-title":"Acetylation and deacetylation in cancer stem-like cells","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-015-0400-3","article-title":"CDKN1A histone acetylation and gene expression relationship in gastric adenocarcinomas","volume":"17","author":"Wisnieski","year":"2017","journal-title":"Clin Exp Med"},{"key":"B18","author":"Tani","year":""},{"key":"B19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s13058-014-0412-z","article-title":"Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer","volume":"16","author":"Falahi","year":"2014","journal-title":"Breast Cancer Res"},{"key":"B20","first-page":"6","article-title":"A stability based method for discovering structure in clustered data","volume":"7","author":"Ben-Hur","year":"2002","journal-title":"Pac Symp Biocomput"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"Elife"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2017-108","article-title":"TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/bs.mie.2019.05.056","article-title":"Deconvoluting tumor-infiltrating immune cells from RNA-seq data using quanTIseq","volume":"636","author":"Plattner","year":"2020","journal-title":"Methods Enzymol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz287","article-title":"Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II\/III colorectal cancer","volume":"30","author":"Dienstmann","year":"2019","journal-title":"Ann Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1142","article-title":"Immune microenvironment composition in non-small cell lung cancer and its association with survival","volume":"9","author":"Tamminga","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0327-7_19","article-title":"Cell-type enrichment analysis of bulk transcriptomes using xCell","volume":"2020","author":"Aran","year":"2120","journal-title":"Methods Mol Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"2018","author":"Chen","year":"1711","journal-title":"Methods Mol Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.lfs.2016.05.041","article-title":"Overexpressed MALAT1 promotes invasion and metastasis of gastric cancer cells via increasing EGFL7 expression","volume":"157","author":"Deng","year":"2016","journal-title":"Life Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2012.03.012","article-title":"Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma","volume":"93","author":"Yamamura","year":"2012","journal-title":"Exp Mol Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25766","article-title":"BMP8B is a tumor suppressor gene regulated by histone acetylation in gastric cancer","volume":"118","author":"Wisnieski","year":"2017","journal-title":"J Cell Biochem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.793425","article-title":"Development and validation of a novel histone acetylation-related gene signature for predicting the prognosis of ovarian cancer","volume":"10","author":"Dai","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.2.429-440.2000","article-title":"Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms","volume":"20","author":"Massari","year":"2000","journal-title":"Mol Cell Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1242\/dev.138099","article-title":"Ascl2 inhibits myogenesis by antagonizing the transcriptional activity of myogenic regulatory factors","volume":"144","author":"Wang","year":"2017","journal-title":"Development"},{"key":"B37","article-title":"Elevated ASCL2 expression in breast cancer is associated with the poor prognosis of patients","volume":"7","author":"Xu","year":"2017","journal-title":"Am J Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.9363","article-title":"ASCL2 expression contributes to gastric tumor migration and invasion by downregulating miR223 and inducing EMT","volume":"18","author":"Zuo","year":"2018","journal-title":"Mol Med Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2011.187","article-title":"Ice breaking in GPCR structural biology","volume":"33","author":"Zhao","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2014.09.009","article-title":"A new crystal structure fragment-based pharmacophore method for G protein-coupled receptors","volume":"71","author":"Fidom","year":"2015","journal-title":"Methods"},{"key":"B41","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1006\/jmbi.2001.4520","article-title":"An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors","volume":"307","author":"Wittenberger","year":"2001","journal-title":"J Mol Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12943-017-0627-6","article-title":"Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-kappaB signaling pathway","volume":"16","author":"Wang","year":"2017","journal-title":"Mol Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers14010019","article-title":"GPR87 promotes metastasis through the AKT-eNOS-NO axis in lung adenocarcinoma","volume":"14","author":"Ahn","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms161024319","article-title":"G protein-coupled receptor 87 (GPR87) promotes cell proliferation in human bladder cancer cells","volume":"16","author":"Zhang","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s42003-022-03506-6","article-title":"GPR87 promotes tumor cell invasion and mediates the immunogenomic landscape of lung adenocarcinoma","volume":"5","author":"Bai","year":"2022","journal-title":"Commun Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2015.04.798","article-title":"The neuron-derived orphan receptor 1 (NOR1) is induced upon human alternative macrophage polarization and stimulates the expression of markers of the M2 phenotype","volume":"241","author":"De Paoli","year":"2015","journal-title":"Atherosclerosis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"BSR20194337","DOI":"10.1042\/BSR20194337","article-title":"Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer","volume":"40","author":"Lv","year":"2020","journal-title":"Biosci Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(03)00015-7","article-title":"Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression","volume":"13","author":"Yang","year":"2003","journal-title":"Curr Opin Genet Dev"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111871200","article-title":"Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family","volume":"277","author":"Gao","year":"2002","journal-title":"J Biol Chem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.08.008","article-title":"Histone deacetylase 11 as a key regulator of metabolism and obesity","volume":"35","author":"Bhaskara","year":"2018","journal-title":"EBioMedicine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ni.1673","article-title":"The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance","volume":"10","author":"Villagra","year":"2009","journal-title":"Nat Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"8626","DOI":"10.1038\/s41598-017-09211-3","article-title":"Histone\/protein deacetylase 11 targeting promotes Foxp3+ Treg function","volume":"7","author":"Huang","year":"2017","journal-title":"Sci Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-3044","article-title":"HDAC11 regulates glycolysis through the LKB1\/AMPK signaling pathway to maintain hepatocellular carcinoma stemness","volume":"81","author":"Bi","year":"2021","journal-title":"Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101742RR","article-title":"A pan-cancer analysis identifies HDAC11 as an immunological and prognostic biomarker","volume":"36","author":"Li","year":"2022","journal-title":"FASEB J"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-24-09152.2000","article-title":"DCAMKL1 encodes a protein kinase with homology to doublecortin that regulates microtubule polymerization","volume":"20","author":"Lin","year":"2000","journal-title":"J Neurosci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2738","article-title":"DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism","volume":"71","author":"Sureban","year":"2011","journal-title":"Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1477-3155-9-40","article-title":"Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism","volume":"9","author":"Sureban","year":"2011","journal-title":"J Nanobiotechnology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5808","article-title":"Lightfoot SA et\u00a0al, Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism","volume":"6","author":"Sureban","year":"2015","journal-title":"Oncotarget"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3059","article-title":"DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma","volume":"6","author":"Weygant","year":"2015","journal-title":"Oncotarget"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201911_19443","article-title":"DCLK1 promotes Malignant progression of breast cancer by regulating Wnt\/beta-Catenin signaling pathway","volume":"23","author":"Wang","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23414","article-title":"Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1","volume":"9","author":"Fesler","year":"2018","journal-title":"Oncotarget"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.928016","article-title":"Role of glucagon and its receptor in the pathogenesis of diabetes","volume":"13","author":"Jia","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00482-9","article-title":"The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions","volume":"4","author":"Nauck","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2014.08.001","article-title":"Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma","volume":"33","author":"Zhou","year":"2015","journal-title":"Urol Oncol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrendo.2015.122","article-title":"Metabolic functions of FABPs\u2013mechanisms and therapeutic implications","volume":"11","author":"Hotamisligil","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R110.135210","article-title":"Tissue-specific functions in the fatty acid-binding protein family","volume":"285","author":"Storch","year":"2010","journal-title":"J Biol Chem"},{"key":"B68","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s12935-020-01582-4","article-title":"FABP4 promotes invasion and metastasis of colon cancer by regulating fatty acid transport","volume":"20","author":"Tian","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22485","article-title":"Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins","volume":"56","author":"Guaita-Esteruelas","year":"2017","journal-title":"Mol Carcinog"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1159\/000056942","article-title":"Genomic structure, chromosome mapping and expression analysis of the human AXIN2 gene","volume":"93","author":"Dong","year":"2001","journal-title":"Cytogenet Cell Genet"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nature08356","article-title":"Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling","volume":"461","author":"Huang","year":"2009","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2011.01.004","article-title":"Disabled-2 and Axin are concurrently colocalized and underexpressed in lung cancers","volume":"42","author":"Xu","year":"2011","journal-title":"Hum Pathol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-013-1709-6","article-title":"Expression and localization of axin 2 in colorectal carcinoma and its clinical implication","volume":"28","author":"Schaal","year":"2013","journal-title":"Int J Colorectal Dis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/path.5243","article-title":"Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma","volume":"248","author":"Joseph","year":"2019","journal-title":"J Pathol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1422640112","article-title":"Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy","volume":"112","author":"Chen","year":"2015","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.02.013","article-title":"Macrophage regulation of tumor responses to anticancer therapies","volume":"23","author":"De Palma","year":"2013","journal-title":"Cancer Cell"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"B80","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41419-021-03440-1","article-title":"The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP\/PKG signaling pathway","volume":"12","author":"Xiang","year":"2021","journal-title":"Cell Death Dis"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.3390\/ijms21113927","article-title":"Targeting wnt signaling for the treatment of gastric cancer","volume":"21","author":"Koushyar","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1527253\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T05:32:22Z","timestamp":1756791142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1527253\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":81,"alternative-id":["10.3389\/fonc.2025.1527253"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1527253","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"article-number":"1527253"}}